They discovered that tumor cells with a substantial amount of tumor-infiltrating lymphocytes (TILs) contained CD8+ T cells exhibiting characteristics of tissue-resident memory T (TRM) cell differentiation. This evidence concerns the gene CD8A and neoplasm.